Genomics

Skin Genomics Platform-driven DermTech to Present at Conference

DermTech

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its management will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 4:00 p.m. Eastern Time.

Interested parties may access the live webcast of the presentation and, for 30 days following the UBS conference, the archived webcast of the presentation through the “Investor Relations” section of DermTech’s website at: www.DermTech.com.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.

Business Wire

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire has 18 newsrooms worldwide to meet the needs of communications professionals and news media.

Related posts

CS Genetics announces new appointment

PR Newswire

Genomenon & Limbus Partner for Genomic Variant Interpretation

PR Newswire

RevoluGen Wins 2022 BioNewsRound Award for Translational Research

PR Newswire